Research Site — Porto Alegre

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

226

Registered studies

115

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · Relapsed/Refractory Follicular Lymphoma · HR Low-Positive/HER2-Negative Breast Neoplasms

Recently updated registry entries

NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)
NCT06330064 — A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects… (Recruiting)
NCT06065748 — A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.